Add Company
Join Now

Cytimmune Sciences Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cytimmune Sciences's estimated annual revenue is currently $1.4M per year.(i)
  • Cytimmune Sciences's estimated revenue per employee is $155,000

Employee Data

  • Cytimmune Sciences has 9 Employees.(i)
  • Cytimmune Sciences grew their employee count by 0% last year.

Cytimmune Sciences's People

NameTitleEmail/Phone
1
CEO, ChairmanReveal Email/Phone
2
Co-Founder/President & CEOReveal Email/Phone
3
Chief Science OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Cytimmune Sciences?

CytImmune is a global leader in the field of cancer nanomedicine. The company has more than 60 issued and pending patents for its colloidal gold nanotechnology in the United States, European Union, Japan and Canada. We have successfully completed a Phase I clinical trial of CYT-6091 — the first in a series of nanomedicines based on our Aurimune nanomedicine platform. For more information about Aurimune or CytImmune, please visit our website, http://CytImmune.com. To read our opinions on topics relevant to cancer patients and their families, health care professionals, and the research community, visit our blog: http://CytImmune.Blog

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M90%N/A
#2
$7.5M913%N/A
#3
$0.7M913%N/A
#4
$1.2M9-82%N/A
#5
$1.1M90%N/A